Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 156, pseudogene (RN7SL156P)

Target
RN7SL156P
Molecular classification
Other, Pseudogene, Noncoding RNA (pseudogene)
01

Overview

RN7SL156P is a human pseudogene derived from 7SL RNA, which is the noncoding RNA component of the signal recognition particle (SRP) complex. The SRP system is essential in cells for cotranslational targeting of proteins to the endoplasmic reticulum, with the functional 7SL RNA playing a direct architectural and regulatory role in SRP ribonucleoprotein assembly, translation elongation arrest, and translocation to the endoplasmic reticulum. However, RN7SL156P is one of the hundreds of 7SL pseudogenes scattered throughout the human genome, generated primarily as truncated nonfunctional copies via reverse transcription events. These pseudogenes do not encode functional 7SL RNA and are generally believed not to participate in SRP function or protein targeting; most are silent, not expressed, and their biological relevance is limited or unknown. Although some pseudogenes in other gene families can act as competitive endogenous RNAs (ceRNAs), regulate gene expression, sponge microRNAs, or impact cancer and other diseases, there is no evidence for a specific biological, disease, or regulatory function of RN7SL156P itself. It is not recognized as a receptor, enzyme, transporter, or any other canonical drug target class. RN7SL156P is a noncoding pseudogene, not a functional molecule or drug target. Its existence reflects genomic duplication and retrotransposition phenomena, but it currently lacks biological or therapeutic relevance.

Other names
RN7SL156P7SL cytoplasmic RNA pseudogene 1567SL pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 156, pseudogene (RN7SL156P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 156, pseudogene (RN7SL156P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call